- Home
- NVAX vs IIPR Comparison
NVAX vs IIPR Comparison
Compare NVAX & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- IIPR
- Stock Information
- Founded
- NVAX 1987
- IIPR 2016
- Country
- NVAX United States
- IIPR United States
- Employees
- NVAX N/A
- IIPR N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- IIPR Real Estate
- Sector
- NVAX Health Care
- IIPR Finance
- Exchange
- NVAX Nasdaq
- IIPR Nasdaq
- Market Cap
- NVAX 1.3B
- IIPR 1.5B
- IPO Year
- NVAX 1995
- IIPR 2016
- Fundamental
- Price
- NVAX $7.98
- IIPR $57.28
- Analyst Decision
- NVAX Buy
- IIPR Hold
- Analyst Count
- NVAX 7
- IIPR 8
- Target Price
- NVAX $14.29
- IIPR $88.75
- AVG Volume (30 Days)
- NVAX 7.2M
- IIPR 258.1K
- Earning Date
- NVAX 11-11-2025
- IIPR 11-05-2025
- Dividend Yield
- NVAX N/A
- IIPR 13.31%
- EPS Growth
- NVAX N/A
- IIPR N/A
- EPS
- NVAX 2.54
- IIPR 4.63
- Revenue
- NVAX $1,078,718,000.00
- IIPR $287,883,000.00
- Revenue This Year
- NVAX $61.69
- IIPR N/A
- Revenue Next Year
- NVAX N/A
- IIPR N/A
- P/E Ratio
- NVAX $3.25
- IIPR $12.32
- Revenue Growth
- NVAX 9.22
- IIPR N/A
- 52 Week Low
- NVAX $5.01
- IIPR $45.44
- 52 Week High
- NVAX $15.22
- IIPR $138.35
- Technical
- Relative Strength Index (RSI)
- NVAX 51.06
- IIPR 59.50
- Support Level
- NVAX $7.63
- IIPR $55.48
- Resistance Level
- NVAX $8.31
- IIPR $57.68
- Average True Range (ATR)
- NVAX 0.35
- IIPR 1.30
- MACD
- NVAX -0.00
- IIPR 0.18
- Stochastic Oscillator
- NVAX 65.20
- IIPR 83.66
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.